This guidance replaces previous conditional recommendations for the use of these drugs and is based on emerging evidence that they’re not likely to work against omicron.
Academic rigour, journalistic flair
Articles on covid treatment
Displaying all articles
After taking Paxlovid for COVID and appearing to recover, some people – including US President Joe Biden – continue to test positive. What’s going on?
We hear a lot about drug-resistant bacteria. The same thing can happen with viruses.
If you do get COVID and you’re eligible for antiviral treatment, you’ll want to get them quickly. That’s why being prepared is a good idea.
After testing positive for COVID, your medicine prescription will depend on the severity of your symptoms and any other health conditions you have.
Here’s who is eligible, the benefits and side effects to consider.
Most people with COVID will recover at home without any treatment. But some people who are at risk of severe disease could benefit from new medicines to reduce the chance of the disease progressing.
These new antivirals are another way of managing COVID-19. But they’re not a panacea, and could even makes things worse.
The need of the moment is for low- and middle-income countries to improve their own manufacturing capabilities.
Who gets scarce life-saving resources when hospitals are overwhelmed? And how are these decisions made? State and territory governments are yet to answer these difficult questions.
If you feel like you’re having a medical emergency then you should still go to hospital. Expect longer waits and extra precautions.
Top contributors
-
Director, Evidence and Methods, National COVID-19 Clinical Evidence Taskforce; Associate Professor (Research), Cochrane Australia, School of Population Health and Preventive Medicine, Monash University, Monash University
-
Monash University
-
Professor of Law, Australian Centre for Health Law Research, Queensland University of Technology, Queensland University of Technology
-
Professor of End-of-Life Law and Regulation, Australian Centre for Health Law Research, Queensland University of Technology
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Professor in Law, University of Southern Queensland
-
Senior lecturer, Australian National University
-
Professor of Organic Chemistry, Neville Isdell Chair in African-centric Drug Discovery & Development, and Director of the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town
-
Professor of Cancer Virology, University of Leeds
-
Senior Research Fellow, Australian Centre for Health Law Research, Queensland University of Technology
-
Conjoint Professor, School of Medicine and Public Health, University of Newcastle
-
Associate Professor in Viral Immunology, University of Birmingham
-
Professor of general practice, Bond University
-
Pharmacist and PhD Candidate, University of Sydney
-
Research Leader in Virology and Infectious Disease, Griffith University
